Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | 48,875 | reported | 21 Jun 2016 | tx 5+100,067 |
| PFIZER INC | 29,099.96 | reported | 23 Apr 2015 | tx 5+27,137.68 |
| Denali Therapeutics Inc. | 18,111 | reported | 03 Jun 2025 | tx 73+637,176−1,576,887 |
| Juno Therapeutics, Inc. | 12,000 | reported | 17 Jun 2016 | tx 4+199,000−175,000 |
| REGENERON PHARMACEUTICALS, INC. | 2,434 | reported | 03 Jan 2023 | tx 125+224,806−202,817 |
| GENENTECH INC | 0 | reported | 26 Mar 2009 | tx 9+18,750−303,284 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jun 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 6,037 | 0.00 USD | |
| 03 Jun 2025 | GRANT_AWARD | Denali Therapeutics Inc. | 18,111 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | Denali Therapeutics Inc. | 5,967 | 0.00 USD | |
| 31 May 2024 | GRANT_AWARD | Denali Therapeutics Inc. | 17,901 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 4,216 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Denali Therapeutics Inc. | 12,649 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 165 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,929 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 165 | 0.00 USD | |
| 03 Jan 2023 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,929 | 0.00 USD | deriv |
| 23 Nov 2022 | SALE | Denali Therapeutics Inc. | 20,000 | 30.48 USD | |
| 02 Nov 2022 | SALE | Denali Therapeutics Inc. | 11,252 | 30.33 USD | |
| 01 Nov 2022 | SALE | Denali Therapeutics Inc. | 8,748 | 30.20 USD | |
| 29 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 80 | 699.82 USD | |
| 29 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 16 | 702.36 USD | |
| 29 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 20 | 704.83 USD | |
| 30 Sept 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,428 | 413.33 USD | |
| 30 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 3,428 | 698.00 USD | |
| 03 Oct 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,612 | 413.33 USD | |
| 03 Oct 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 3,612 | 718.00 USD | |
| 29 Sept 2022 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 3,798 | 413.33 USD | |
| 29 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 16 | 686.89 USD | |
| 29 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 321 | 687.90 USD | |
| 29 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 208 | 698.44 USD | |
| 29 Sept 2022 | SALE | REGENERON PHARMACEUTICALS, INC. | 160 | 697.29 USD |